Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Theraputics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cells
1.2.3 Immunocyte
1.3 Market by Application
1.3.1 Global Cell Theraputics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Allogeneic Cell Therapy
1.3.3 Autologous Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Theraputics Market Perspective (2017-2028)
2.2 Cell Theraputics Growth Trends by Region
2.2.1 Cell Theraputics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Theraputics Historic Market Size by Region (2017-2022)
2.2.3 Cell Theraputics Forecasted Market Size by Region (2023-2028)
2.3 Cell Theraputics Market Dynamics
2.3.1 Cell Theraputics Industry Trends
2.3.2 Cell Theraputics Market Drivers
2.3.3 Cell Theraputics Market Challenges
2.3.4 Cell Theraputics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Theraputics Players by Revenue
3.1.1 Global Top Cell Theraputics Players by Revenue (2017-2022)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2017-2022)
3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Theraputics Revenue
3.4 Global Cell Theraputics Market Concentration Ratio
3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2021
3.5 Cell Theraputics Key Players Head office and Area Served
3.6 Key Players Cell Theraputics Product Solution and Service
3.7 Date of Enter into Cell Theraputics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Theraputics Breakdown Data by Type
4.1 Global Cell Theraputics Historic Market Size by Type (2017-2022)
4.2 Global Cell Theraputics Forecasted Market Size by Type (2023-2028)
5 Cell Theraputics Breakdown Data by Application
5.1 Global Cell Theraputics Historic Market Size by Application (2017-2022)
5.2 Global Cell Theraputics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Theraputics Market Size (2017-2028)
6.2 North America Cell Theraputics Market Size by Type
6.2.1 North America Cell Theraputics Market Size by Type (2017-2022)
6.2.2 North America Cell Theraputics Market Size by Type (2023-2028)
6.2.3 North America Cell Theraputics Market Share by Type (2017-2028)
6.3 North America Cell Theraputics Market Size by Application
6.3.1 North America Cell Theraputics Market Size by Application (2017-2022)
6.3.2 North America Cell Theraputics Market Size by Application (2023-2028)
6.3.3 North America Cell Theraputics Market Share by Application (2017-2028)
6.4 North America Cell Theraputics Market Size by Country
6.4.1 North America Cell Theraputics Market Size by Country (2017-2022)
6.4.2 North America Cell Theraputics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cell Theraputics Market Size (2017-2028)
7.2 Europe Cell Theraputics Market Size by Type
7.2.1 Europe Cell Theraputics Market Size by Type (2017-2022)
7.2.2 Europe Cell Theraputics Market Size by Type (2023-2028)
7.2.3 Europe Cell Theraputics Market Share by Type (2017-2028)
7.3 Europe Cell Theraputics Market Size by Application
7.3.1 Europe Cell Theraputics Market Size by Application (2017-2022)
7.3.2 Europe Cell Theraputics Market Size by Application (2023-2028)
7.3.3 Europe Cell Theraputics Market Share by Application (2017-2028)
7.4 Europe Cell Theraputics Market Size by Country
7.4.1 Europe Cell Theraputics Market Size by Country (2017-2022)
7.4.2 Europe Cell Theraputics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Theraputics Market Size (2017-2028)
8.2 Asia-Pacific Cell Theraputics Market Size by Type
8.2.1 Asia-Pacific Cell Theraputics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell Theraputics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell Theraputics Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell Theraputics Market Size by Application
8.3.1 Asia-Pacific Cell Theraputics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell Theraputics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell Theraputics Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell Theraputics Market Size by Region
8.4.1 Asia-Pacific Cell Theraputics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell Theraputics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell Theraputics Market Size (2017-2028)
9.2 Latin America Cell Theraputics Market Size by Type
9.2.1 Latin America Cell Theraputics Market Size by Type (2017-2022)
9.2.2 Latin America Cell Theraputics Market Size by Type (2023-2028)
9.2.3 Latin America Cell Theraputics Market Share by Type (2017-2028)
9.3 Latin America Cell Theraputics Market Size by Application
9.3.1 Latin America Cell Theraputics Market Size by Application (2017-2022)
9.3.2 Latin America Cell Theraputics Market Size by Application (2023-2028)
9.3.3 Latin America Cell Theraputics Market Share by Application (2017-2028)
9.4 Latin America Cell Theraputics Market Size by Country
9.4.1 Latin America Cell Theraputics Market Size by Country (2017-2022)
9.4.2 Latin America Cell Theraputics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Theraputics Market Size (2017-2028)
10.2 Middle East & Africa Cell Theraputics Market Size by Type
10.2.1 Middle East & Africa Cell Theraputics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell Theraputics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell Theraputics Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell Theraputics Market Size by Application
10.3.1 Middle East & Africa Cell Theraputics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell Theraputics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell Theraputics Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell Theraputics Market Size by Country
10.4.1 Middle East & Africa Cell Theraputics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell Theraputics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Details
11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction
11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2017-2022)
11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Developments
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Cell Theraputics Introduction
11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2017-2022)
11.2.5 Bluebird Bio Recent Developments
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Details
11.3.2 Crispr Therapeutics Business Overview
11.3.3 Crispr Therapeutics Cell Theraputics Introduction
11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2017-2022)
11.3.5 Crispr Therapeutics Recent Developments
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Details
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2017-2022)
11.4.5 Roche (Spark Therapeutics) Recent Developments
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Details
11.5.2 PTC Therapeutics Business Overview
11.5.3 PTC Therapeutics Cell Theraputics Introduction
11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2017-2022)
11.5.5 PTC Therapeutics Recent Developments
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Details
11.6.2 Moderna Therapeutics Business Overview
11.6.3 Moderna Therapeutics Cell Theraputics Introduction
11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2017-2022)
11.6.5 Moderna Therapeutics Recent Developments
11.7 Quanterix
11.7.1 Quanterix Company Details
11.7.2 Quanterix Business Overview
11.7.3 Quanterix Cell Theraputics Introduction
11.7.4 Quanterix Revenue in Cell Theraputics Business (2017-2022)
11.7.5 Quanterix Recent Developments
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Details
11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction
11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2017-2022)
11.8.5 Brainstorm Cell Therapeutics Inc. Recent Developments
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Details
11.9.2 Lineage Cell Therapeutics Business Overview
11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction
11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2017-2022)
11.9.5 Lineage Cell Therapeutics Recent Developments
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Details
11.10.2 Cti Biopharma Business Overview
11.10.3 Cti Biopharma Cell Theraputics Introduction
11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2017-2022)
11.10.5 Cti Biopharma Recent Developments
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Details
11.11.2 Atara Biotherapeutics, Inc Business Overview
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction
11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2017-2022)
11.11.5 Atara Biotherapeutics, Inc Recent Developments
11.12 Adaptimmune
11.12.1 Adaptimmune Company Details
11.12.2 Adaptimmune Business Overview
11.12.3 Adaptimmune Cell Theraputics Introduction
11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2017-2022)
11.12.5 Adaptimmune Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer